Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer

Articles Ahead of Print

Regulation of Breast Cancer Progression by Noncoding RNAs

Volume:20
Ravishkumar L Akshaya, Muthukumar Rohini and Nagarajan Selvamurugan*

Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling

Volume:20
Zhi Li, Wen-Qi Gao, Peng Wang, Tian-Qi Wang, Wen-Chao Xu, Xin-Yu Zhu and Hui Liu*

MALAT1 as a Versatile Regulator of Cancer: Overview of the updates from Predatory role as Competitive Endogenous RNA to Mechanistic In-sights

Volume:20
Ammad Ahmad Farooqi*, Evangelia Legaki, Maria Gazouli, Silvia Rinaldi and Rossana Berardi

Tumor-induced Metabolism and T Cells Located in Tumor Environment.

Volume:20
Sara Iranparast, Sanaz Tayebi, Fatemeh Ahmadpour and Bahman Yousefi*

Targeting NUPR1 for Cancer Treatment: A Risky Endeavor

Volume:20
Salma M. A. Mansour, Sahar A. Ali, Shaira Nofal and Sameh H. Soror*

Emerging Multi-Cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT

Volume:20
Yellamandayya Vadlamudi, Debasish Kumar Dey and Sun Chul Kang*

Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL

Volume:20
Sven Nilsson*, Alexander Stein, Christian Rolfo, Anne Kranich, Julia Mann, Konstantinos Papadimitriou, Susann Theile, Stefanie Amberg and Carsten Bokemeyer

The Roles of Alternative Splicing in Tumor-immune Cell Interactions

Volume:20
Yue Wang, Honglei Zhang, Baowei Jiao*, Jianyun Nie, Xiyin Li, Wenhuan Wang and Hairui Wang

Targeting MUC15 Protein in Cancer: Molecular Mechanisms and Therapeutic Perspectives

Volume:20
Simei Zhang, Wunai Zhang, Ying Xiao, Tao Qin, Yangyang Yue, Weikun Qian, Xin Shen, Qingyong Ma and Zheng Wang*

CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia

Volume:20
Hadeil ME Idris, Hiba B Khalil, Jeremy Mills and Abozer Y. Elderdery*

HOTAIR Competitively Binds MiRNA330 as a Molecular Sponge to Increase the Resistance of Gastric Cancer to Trastuzumab

Volume:20
Liangyu Bie, Suxia Luo*, Dan Li, Yan Wei, Yu Mu, Xiaobing Chen, Saiqi Wang, Ping Guo and Xiaoyu Lu

Immunotherapy: A Potential Approach To Targeting Cancer Stem Cells

Volume:20
Wenjun Wang, Ling Bai, Dongsheng Xu, Wei Li and Jiuwei Cui*

USP48 Sustains Chemoresistance and Metastasis in Ovarian Cancer

Volume:20
Xuemeng Lei, Xukun Li, Hongyan Chen and Zhihua Liu*

Neoadjuvant Chemotherapy Induces the Appearance of New Copy Number Aberrations in Breast Tumor and is Associated with Metastasis

Volume:20
Nikolai V. Litviakov*, Marina K. Ibragimova, Matvey M. Tsyganov, Artem V. Doroshenko, Eugeniy Yu. Garbukov and Elena M. Slonimskaya

Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma

Volume:20
Sekaran Balaji, Radhakrishnan Santhi, Usha Kim, Veerappan Muthukkaruppan, Chidambaranathan Gowri Priya and Ayyasamy Vanniarajan*

Synthesis and Cytotoxic Activity of Azine Derivatives of 6- Hydroxyxanthanodiene

Volume:20
Margarita E. Neganova, Sergey G. Klochkov, Sergey A. Pukhov, Svetlana V. Afanasieva, Yulia R. Aleksandrova, Ekaterina Yu. Yandulova, Marco Avila-Rodriguez, Liudmila M. Mikhaleva, Vladimir N. Nikolenko, Siva G. Somasundaram, Cecil E. Kirkland and Gjumrakch Aliev*

Withdrawn: The Structural Bioinformatics Analysis of Biophenolic Lignan- Estrogen Receptor Interaction

Volume:17
Farzaneh Mohamadyar-Toupkanlou*, Mina Esfandiari, Mahshid Sadat Kashef-Saberi, Mahboubeh Kabiri Renani and Masoud Soleimani